Fred Alger Management, LLC Exact Sciences Corp Transaction History

Fred Alger Management, LLC

$20.1 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$56.27 - $73.77 $5.38 Million - $7.05 Million	-95,628 Reduced 91.7%	8,654 $597,000
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $2.79 Million - $3.58 Million	47,263 Added 82.89%	104,282 $7.71 Million
Q3 2023 Nov 14, 2023	SELL	$65.94 - $99.04 $3.52 Million - $5.29 Million	-53,405 Reduced 48.36%	57,019 $3.89 Million
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $5.07 Million - $7.68 Million	80,848 Added 273.36%	110,424 $10.4 Million
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $1.4 Million - $2.09 Million	29,576 New	29,576 $2.01 Million
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $2.76 Million - $3.8 Million	-30,616 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $15.2 Million - $22.6 Million	-162,480 Reduced 84.14%	30,616 $3.81 Million
Q1 2021 May 17, 2021	SELL	$116.57 - $155.01 $717,488 - $954,086	-6,155 Reduced 3.09%	193,096 $25.4 Million
Q4 2020 Feb 16, 2021	BUY	$99.61 - $142.12 $12.5 Million - $17.8 Million	125,083 Added 168.65%	199,251 $26.4 Million
Q3 2020 Nov 13, 2020	BUY	$72.92 - $102.01 $1.18 Million - $1.64 Million	16,116 Added 27.76%	74,168 $7.56 Million
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $325,189 - $541,010	5,833 Added 11.17%	58,052 $5.05 Million
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $296,946 - $818,287	-7,835 Reduced 13.05%	52,219 $3.03 Million
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $48.5 Million - $62.3 Million	-624,641 Reduced 91.23%	60,054 $5.55 Million
Q3 2019 Nov 14, 2019	SELL	$90.37 - $122.49 $852,550 - $1.16 Million	-9,434 Reduced 1.36%	684,695 $61.9 Million
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $445,312 - $587,249	-4,975 Reduced 0.71%	694,129 $81.9 Million
Q1 2019 May 14, 2019	SELL	$61.98 - $96.5 $3.76 Million - $5.86 Million	-60,710 Reduced 7.99%	699,104 $60.6 Million
Q4 2018 Feb 14, 2019	SELL	$56.04 - $82.66 $4.48 Million - $6.61 Million	-80,011 Reduced 9.53%	759,814 $47.9 Million
Q3 2018 Nov 14, 2018	SELL	$48.29 - $80.6 $24.7 Million - $41.2 Million	-510,821 Reduced 37.82%	839,825 $66.3 Million
Q2 2018 Jul 19, 2018	SELL	$37.84 - $69.96 $56.5 Million - $105 Million	-1,494,242 Reduced 52.52%	1,350,646 $80.8 Million
Q1 2018 May 10, 2018	BUY	$39.82 - $57.53 $42.9 Million - $61.9 Million	1,076,357 Added 60.86%	2,844,888 $115 Million
Q4 2017 Feb 14, 2018	SELL	$46.49 - $60.51 $13.6 Million - $17.7 Million	-291,871 Reduced 14.17%	1,768,531 $92.9 Million
Q3 2017 Nov 14, 2017	BUY	$37.05 - $47.12 $76.3 Million - $97.1 Million	2,060,402	2,060,402 $97.1 Million

Others Institutions Holding EXAS

# of Institutions

610

Shares Held

166M

Call Options Held

1.93M

Put Options Held

1.23M

Vanguard Group Inc Valley Forge, PA

18.2M
Shares

$1.24 Billion
0.02% of portfolio
Capital World Investors Los Angeles, CA

16.5M
Shares

$1.12 Billion
0.12% of portfolio
Wellington Management Group LLP Boston, MA

14.8M
Shares

$1.01 Billion
0.11% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$822 Million
0.01% of portfolio
State Street Corp Boston, MA

8.21M
Shares

$559 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $12B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account